Alert Icon

Beware of scams

We are aware of scams coming from email and social media where people try to impersonate us. We will never ask you for money or your bank details.

Learn more about what to look out for and how to protect yourself

CEO of British Patient Capital appointed to Government taskforce

Press release 26 May 2022

Judith Hartley, CEO of British Patient Capital and British Business Investments, has been appointed to a new Women-Led High Growth Taskforce set up by the Cabinet Office.

Chaired by Anne Boden, CEO of Starling Bank, the aim of the Taskforce is to influence high-growth investors and the wider business community, and raise the aspirations of the next generation of women entrepreneurs.

The formation of a Taskforce with a laser focus on increasing the number of women-led, high growth businesses is incredibly important. Diversity within investment teams and in the companies they back ensures diversity of ideas – and that is a cornerstone of innovation. At British Patient Capital, we work hard to ensure we have good diversity at all levels within our team. As the UK’s largest investor in venture and growth capital, we firmly believe we have a role to play in demonstrating best practice and driving change across the industry. I look forward to supporting the Taskforce to improve awareness and understanding of the key barriers faced by female entrepreneurs in accessing high growth capital, and championing the vital role of women-led business in the UK economy. Judith Hartley CEO, British Patient Capital

Further Information

Notes to editors

About British Patient Capital

British Patient Capital is the trading name of British Patient Capital Limited, a wholly-owned commercial subsidiary of British Business Bank plc, the UK government’s economic development bank. It forms part of the British Business Bank plc’s commercial arm.

Its mission is to enable long-term investment in innovative firms led by ambitious entrepreneurs who want to build large scale businesses. Launched in June 2018, British Patient Capital has £2.5bn to invest over 10 years in venture and venture growth capital to support high growth potential innovative UK businesses in accessing the long-term financing they require to scale up. Find out more at

British Business Bank plc and its subsidiary entities are not banking institutions and do not operate as such. They are not authorised or regulated by the Prudential Regulation Authority (PRA) or the Financial Conduct Authority (FCA). A complete legal structure chart for British Business Bank plc and its subsidiaries can be found on the British Business Bank plc website.

British Patient Capital makes commitments and invests on its own behalf and on behalf of third-party investors whose investments British Patient Capital manages.